Skip to main content
Top

Current Oncology Reports

Issue 7/2019

Content (10 Articles)

Multiple Myeloma Geriatric Oncology (AR MacKenzie, Section Editor)

Management of Newly Diagnosed Elderly Multiple Myeloma Patients

Crystal Antoine-Pepeljugoski, Marc Justin Braunstein

Geriatric Oncology Geriatric Oncology (AR MacKenzie, Section Editor)

Immunotherapy in Older Adults with Cancer

Richard Curtis Godby, Douglas B. Johnson, Grant R. Williams

Glioblastoma Neuro-oncology (Y Umemura, Section Editor)

Targeted Therapies for the Treatment of Glioblastoma in Adults

Ding Fang Chuang, Xuling Lin

Lymphoma Lymphomas (MR Smith, Section Editor)

Follicular Lymphoma: Diagnostic and Prognostic Considerations in Initial Treatment Approach

Kirsten M. Boughan, Paolo F. Caimi

Lymphoma Lymphomas (MR Smith, Section Editor)

Is It Time to Revisit the Role of Allogeneic Transplantation in Lymphoma?

Satish Shanbhag, Nina Wagner-Johnston, Richard F. Ambinder, Richard J. Jones

Langerhans Cell Histiocytosis Lymphomas (MR Smith, Section Editor)

Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim–Chester Disease, Destombes–Rosai–Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders

Matthias Papo, Fleur Cohen-Aubart, Ludovic Trefond, Adeline Bauvois, Zahir Amoura, Jean-François Emile, Julien Haroche

Checkpoint Inhibitors Gastrointestinal Cancers (J Meyer, Section Editor)

Current Status of Immunotherapies for Treating Pancreatic Cancer

Annie A. Wu, Elizabeth Jaffee, Valerie Lee

Fertility Breast Cancer (B Overmoyer, Section Editor)

Issues with Fertility in Young Women with Breast Cancer

Nicole Christian, Mary L. Gemignani

Gynecologic Cancer Gynecologic Cancers (NS Reed, Section Editor)

How Do We Follow Up Patients With Endometrial Cancer?

Mette Moustgaard Jeppesen, Ole Mogensen, Dorte G. Hansen, Stinne H. Bergholdt, Pernille T. Jensen

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine